Belén Alejos

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Nanina Anderegg, Klea Panayidou, Yao Abo et al. · Clinical Infectious Diseases · 2017 · 122 citations · Full text

Public Health, Infectious Disease Control, Population Health Sciences +17

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial

Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barrúz et al. · The Lancet HIV · 2021 · 105 citations

Medicine, Immunology, Aging +12

HIV Infection in Migrant Populations in the European Union and European Economic Area in 2007–2012

Víctoria Hernando, Débora Álvarez-del Arco, Belén Alejos et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 103 citations

Public Health, Infectious Diseases, Population Health Sciences +17

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13